Press release
Psoriasis Therapeutics Market Size, Top Companies, Share, Growth And Forecast 2033 | CAGR 9.3%
Psoriasis Therapeutics Market
Read More: https://www.globenewswire.com/en/news-release/2022/10/23/2539592/0/en/Global-Psoriasis-Therapeutics-Market-to-Reach-55-8-Billion-by-2031-Says-AMR.html
Psoriasis Therapeutics Market Statistics: The global Psoriasis Therapeutics market is estimated to reach $55.8 billion by 2031, growing at a CAGR of 9.3% from 2022 to 2031.
Psoriasis Therapeutics Market Growth Drivers:
Increasing Prevalence of Psoriasis: The growing prevalence of psoriasis worldwide is a significant driver for the psoriasis therapeutics market. The chronic autoimmune skin condition affects a substantial portion of the global population, leading to a rising demand for effective treatments.
Advancements in Biologic Therapies: The development of biologic drugs, including monoclonal antibodies targeting specific pathways involved in psoriasis, has significantly improved treatment options. Biologics have shown efficacy in managing moderate to severe psoriasis, driving their adoption in the market.
Pipeline Developments and Novel Therapies: Ongoing research and development activities have led to the discovery of novel therapeutic approaches for psoriasis. The introduction of new drugs and therapies with improved efficacy and safety profiles contributes to market growth.
Collaborations and Partnerships: Collaborations between pharmaceutical companies, research institutions, and healthcare organizations contribute to the development and commercialization of innovative psoriasis treatments. Partnerships often facilitate the sharing of resources and expertise in drug development.
Technological Advancements in Drug Delivery: Innovations in drug delivery systems, such as topical formulations, injectables, and oral medications, improve patient compliance and convenience. Enhanced drug delivery technologies can positively influence the market.
Click To Get Sample Copy: https://www.alliedmarketresearch.com/request-sample/3747
The segments and sub-section of Psoriasis Therapeutics market is shown below:
By Drug Class: TNF-alpha Inhibitors, Interleukin Inhibitors, Others
By Type: Plaque Psoriasis, Psoriatic Arthritis, Others
By Route of Administration: Oral, Parenteral, Topical
Some of the key players involved in the Market are: AbbVie, Amgen, Bausch Health Companies, Eli Lilly and Company, Johnson & Johnson (J&J), Leo Pharma, Novan, Novartis, Pfizer, Viatris.
Important years considered in the Psoriasis Therapeutics study:
Historical year - 2017-2022; Base year - 2023; Forecast period** - 2022 to 2032 [** unless otherwise stated]
If opting for the Global version of Psoriasis Therapeutics Market; then below country analysis would be included:
- North America (USA, Canada and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.)
- Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Key Questions Answered with this Study:
1) What makes Psoriasis Therapeutics Market feasible for long term investment?
2) How influencing factors driving the demand of Psoriasis Therapeutics in next few years?
3) Territory that may see steep rise in CAGR & Y-O-Y growth?
4) What geographic region would have better demand for product/services?
5) What opportunity emerging territory would offer to established and new entrants in Psoriasis Therapeutics market?
6) What strategies of big players help them acquire share in mature market?
7) Know value chain areas where players can create value?
8) What is the impact analysis of various factors in the Global Psoriasis Therapeutics market growth?
9) Risk side analysis connected with service providers?
Introduction about Psoriasis Therapeutics Market
Psoriasis Therapeutics Market Size (Sales) Market Share by Type (Product Category)
Psoriasis Therapeutics Market by Application/End Users
Psoriasis Therapeutics Sales (Volume) and Market Share Comparison by Applications
Global Psoriasis Therapeutics Sales and Growth Rate (2022-2032)
Psoriasis Therapeutics Competition by Players/Suppliers, Region, Type, and Application
Psoriasis Therapeutics (Volume, Value, and Sales Price) table defined for each geographic region defined.
Psoriasis Therapeutics Players/Suppliers Profiles and Sales Data
Key Raw Materials Analysis & Price Trends
Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis
……..and view more in complete table of Contents
Procure Complete Report @ https://www.alliedmarketresearch.com/checkout-final/3de97bb91206c21ec6022b7e011373db
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
Contact Us:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriasis Therapeutics Market Size, Top Companies, Share, Growth And Forecast 2033 | CAGR 9.3% here
News-ID: 3470486 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Psoriasis
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Major Market Shift in Psoriasis Industry: Combination Therapy Is An Emerging Tre …
What Is the Forecasted Market Size and Growth Rate for the Psoriasis Market?
The market scope for psoriasis has seen substantial growth in the past years. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, with a compound annual growth rate (CAGR) of 11.1%. Factors such as epidemiology, patient awareness and education, along with healthcare infrastructure and access have contributed to the growth in the…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
Psoriasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Psoriasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H1 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape.
Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up…
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It…
